AA-RISEDRONATE DR
AA PHARMA INC
Quick answers
Is there a shortage of AA-RISEDRONATE DR in Canada?
No. There is no current shortage of AA-RISEDRONATE DR 35MG reported to Health Canada. Stock can still vary from one pharmacy to another.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Closest Matches
ACTONEL DR
ABBVIE CORPORATION
Other Products
ACTONEL
ABBVIE CORPORATION
PHL-RISEDRONATE
PHARMEL INC
DOM-RISEDRONATE
DOMINION PHARMACAL
RIVA-RISEDRONATE
LABORATOIRE RIVA INC.
PENDO-RISEDRONATE
PENDOPHARM DIVISION OF PHARMASCIENCE INC
DIN
02493268
Strength
35MG
Dosage Form
Tablet (Delayed-Release)
Route
Oral
Active Ingredient
RISEDRONATE SODIUM (RISEDRONATE SODIUM HEMIPENTAHYDRATE)
See all RISEDRONATE SODIUM (RISEDRONATE SODIUM HEMIPENTAHYDRATE) products →Compare with another product →
Shortage History
No shortage or discontinuation reports on file for this product.
Other Products from AA PHARMA INC
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
10MG · DIN 02420333
DIN 00784400
DIN 02248764
DIN 02248763
50MG · DIN 02458748
200MG · DIN 02458756
25MG · DIN 02248034
100MG · DIN 02248035
30MG · DIN 00771376
60MG · DIN 00771384
67MG · DIN 02243180
200MG · DIN 02239864